Skip to main content

Stem cells and exosomes: what is the difference

One delivers living cells. The other delivers the messages cells send. Here is what each contains, what it is studied to do, and how our medical team chooses.

Illustrative macro film comparing a living mesenchymal stromal cell and the extracellular vesicles it releases. Living cells vs signalling cargo

Editorial illustration of cell biology. It does not depict a procedure or a treatment outcome.

The short answer

One delivers cells, the other delivers messages

Mesenchymal stromal cells are living cells that release biological signals to the cells around them; ours come from Wharton's jelly, the gelatinous tissue inside a donated umbilical cord. Exosomes are some of those signals, collected on their own: tiny particles carrying proteins, lipids, signalling molecules and RNA, with no living cells in the preparation.

That single difference explains most of the others, including how each is prepared, how it is given, and which goals it is usually planned around.

Side by side

The same six questions, asked of both

What it is

What is given?

MSC treatment
Living mesenchymal stromal cells, prepared as a dose with a viable cell count
Exosome preparation
A cell-free preparation of the tiny vesicles cells release

Where does it come from?

MSC treatment
Wharton's jelly, the gelatinous tissue inside an umbilical cord donated after a healthy birth, then isolated and expanded in the laboratory
Exosome preparation
Cells in culture, whose released vesicles are collected, concentrated and characterised

What is studied

What is it studied to do?

MSC treatment
Paracrine signalling, immunomodulation, growth factors and angiogenic signalling
Exosome preparation
Transfer of cargo between cells, inflammatory signalling and support for the tissue environment

Where is it most often used?

MSC treatment
Autoimmune and inflammatory conditions, neurological diagnoses, and joint and tendon problems
Exosome preparation
Skin quality, thinning hair and the scalp, and joint, tendon and soft-tissue concerns

How it is planned

How is it given?

MSC treatment
Intravenous infusion, image-guided injection, or another route your plan names, administered by a physician
Exosome preparation
A skin or scalp procedure, a local injection, or an intravenous infusion, administered by a clinician

What documentation comes with it?

MSC treatment
A batch certificate of analysis with identity, sterility, endotoxin, viable cell count, passage and storage, plus donor screening and traceability
Exosome preparation
The source of the preparation, how it was produced and characterised, its release testing, and its storage and handling

Stem cells and exosomes are different.

One is a living cell. The other is a cell-derived messenger. The difference shapes how each is sourced, how it is given, and which one our medical team may propose for your case.

Illustration of a mesenchymal stromal cell releasing extracellular vesicles toward neighboring tissue cells
  1. 01 / SOURCE

    Living source cells

    Mesenchymal stromal cells are living cells. Their behavior depends on source, handling, dose, and biological context.

  2. 02 / SIGNAL

    Released signals

    Cells release soluble factors and extracellular vesicles. Exosomes are one subset of these small vesicles.

  3. 03 / RESPONSE

    Local cell response

    Nearby cells may respond to those signals. That biological rationale is where treatment planning starts, not a promise of a result.

Illustrative visualization, not to scale. It does not predict a treatment response.Stem cells and exosomes explained

How our medical team chooses between them

The choice follows the goal rather than the category. Immunomodulation is the most studied property of Wharton's jelly MSCs, which is why autoimmune, inflammatory and neurological cases usually start there. Skin quality and scalp concerns more often begin with an exosome preparation, and joint and tendon problems are discussed either way depending on what the imaging and examination show.

Some patients also prefer a preparation that contains no living cells, and some cases make a cell product less suitable. Our medical team explains the reasoning either way, in writing, before anything is agreed.

  • What you want to improve, described in terms that can be reviewed later
  • What your records, examination and imaging show about the target
  • Which route reaches that target, and what the day would involve
  • Whether a cell-free preparation suits your case better than a cell product
Wide evening view across the Bosphorus in Istanbul

Editorial view of Istanbul. This is not a clinic, medical facility, procedure, or treatment outcome.

A comparison should end in a clear next step

Send your records and tell us what you would like to improve. Our medical team will say which of the two we would propose for your case, and why.

Stem cells and exosomes: your questions

What is the difference between stem cells and exosomes?

A stem cell product contains living mesenchymal stromal cells. An exosome preparation contains the tiny signalling particles cells release, and no cells at all. One delivers cells, the other delivers the messages cells send.

Which one is better?

Neither is better as a category. They suit different goals. Our medical team chooses from what you want to improve, what your records and examination show, and which route reaches the target, then explains the reasoning in your plan.

Can they be used together?

The two are sometimes planned together, and sometimes one alone is the better answer. Our medical team explains what each component is there for, prices them separately, and is clear that you can take one without the other.

Which is used for skin and hair?

Exosome preparations are the more common choice for skin quality and scalp concerns, and those are among the most researched applications. Our team starts with the cause of the concern, records a photographic baseline, and sets a goal that photographs at the review point can show.

Which is used for autoimmune and inflammatory conditions?

Wharton's jelly mesenchymal stromal cells are the more usual starting point, because immunomodulation is their most studied property. Suitability is confirmed after our medical team reviews your specialist reports and current treatment.

International patient support

Not sure which one fits your case?

Send your diagnosis, recent imaging and current medication, and tell us what you would like to improve. Our medical team will explain which approach we would propose, why, and what treatment in Istanbul would involve.

Your review starts from home

Nothing needs to be booked to begin. Our patient coordination team plans your visit to Istanbul once your treatment plan is agreed.